HARVARD BIOSCIENCE, INC. (HBIO) Gross Margin
- Gross margin · 12 months: Value 58.16%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 58.16% | Gross profit / revenue. Period ending 2026-06-30. $51.07M ÷ $87.81M × 100 ≈ 58.16% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 51.07M USD | Gross Profit |
| Revenue | 87.81M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 36.74M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $51.07M | $87.81M | $36.74M | 58.16% |
| 2026-03-31 | $49.97M | $85.53M | $35.56M | 58.42% |
| 2025-12-31 | $49.91M | $86.55M | $36.64M | 57.67% |
| 2025-09-30 | $49.75M | $87.37M | $37.62M | 56.94% |
| 2025-06-30 | $50.49M | $88.75M | $38.26M | 56.89% |
| 2025-03-31 | $52.18M | $91.40M | $39.22M | 57.09% |
| 2024-12-31 | $54.77M | $94.14M | $39.37M | 58.18% |
| 2024-09-30 | $57.08M | $97.73M | $40.65M | 58.40% |
| 2024-06-30 | $59.04M | $101.13M | $42.08M | 58.39% |
| 2024-03-31 | $62.50M | $106.79M | $44.29M | 58.52% |
| 2023-12-31 | $66.07M | $112.25M | $46.18M | 58.86% |
| 2023-09-30 | $65.58M | $112.52M | $46.95M | 58.28% |
| 2023-06-30 | $63.02M | $114.08M | $51.06M | 55.24% |
| 2023-03-31 | $62.99M | $114.53M | $51.54M | 55.00% |
| 2022-12-31 | $60.82M | $113.33M | $52.52M | 53.66% |
| 2022-09-30 | $64.55M | $117.96M | $53.42M | 54.72% |
| 2022-06-30 | $68.68M | $120.70M | $52.02M | 56.90% |
| 2022-03-31 | $68.40M | $120.69M | $52.30M | 56.67% |
| 2021-12-31 | $67.65M | $118.90M | $51.25M | 56.90% |
| 2021-09-30 | $65.80M | $116.83M | $51.03M | 56.32% |
| 2021-06-30 | $62.99M | $111.21M | $48.22M | 56.64% |
| 2021-03-31 | $60.49M | $105.32M | $44.83M | 57.44% |
| 2020-12-31 | $58.04M | $102.10M | $44.06M | 56.85% |
| 2020-09-30 | $57.57M | $102.09M | $44.52M | 56.39% |
| 2020-06-30 | $59.05M | $105.47M | $46.42M | 55.99% |
| 2020-03-31 | $61.15M | $111.75M | $50.59M | 54.72% |
| 2019-12-31 | $64.32M | $116.18M | $51.85M | 55.37% |
| 2019-09-30 | $65.83M | $119.06M | $53.23M | 55.29% |
| 2019-06-30 | $66.67M | $120.28M | $53.61M | 55.43% |
| 2019-03-31 | $66.07M | $122.22M | $56.15M | 54.06% |
| 2018-12-31 | $63.18M | $120.77M | $57.59M | 52.31% |
| 2018-09-30 | $63.89M | $133.04M | $69.15M | 48.02% |
| 2018-06-30 | $57.57M | $123.12M | $65.55M | 46.76% |
| 2018-03-31 | $51.29M | $110.56M | $59.27M | 46.39% |
| 2017-12-31 | $47.60M | $101.88M | $54.28M | 46.72% |
| 2017-09-30 | $46.53M | $100.83M | $54.30M | 46.15% |
| 2017-06-30 | $46.58M | $100.79M | $54.21M | 46.22% |
| 2017-03-31 | $46.97M | $101.71M | $54.74M | 46.18% |
| 2016-12-31 | $48.41M | $104.52M | $56.11M | 46.32% |
| 2016-09-30 | $49.23M | $106.48M | $57.24M | 46.24% |
| 2016-06-30 | $49.27M | $107.20M | $57.93M | 45.96% |
| 2016-03-31 | $50.19M | $109.86M | $59.67M | 45.68% |
| 2015-12-31 | $48.72M | $108.66M | $59.94M | 44.84% |
| 2015-09-30 | $49.66M | $110.66M | $61.00M | 44.88% |
| 2015-06-30 | $49.38M | $110.38M | $61.00M | 44.74% |
| 2015-03-31 | $49.06M | $108.53M | $59.47M | 45.20% |
| 2014-12-31 | $49.34M | $108.66M | $59.32M | 45.41% |
| 2014-09-30 | $47.53M | $106.15M | $58.62M | 44.77% |
| 2014-06-30 | $47.38M | $105.84M | $58.46M | 44.77% |
| 2014-03-31 | $47.20M | $104.98M | $57.78M | 44.96% |
| 2013-12-31 | $47.70M | $105.17M | $57.48M | 45.35% |
| 2013-09-30 | $49.07M | $105.57M | $56.49M | 46.49% |
| 2013-06-30 | $49.77M | $106.53M | $56.77M | 46.71% |
| 2013-03-31 | $51.28M | $108.94M | $57.65M | 47.08% |
| 2012-12-31 | $52.42M | $111.17M | $58.75M | 47.15% |
| 2012-09-30 | $52.24M | $111.95M | $59.71M | 46.66% |
| 2012-06-30 | $52.12M | $112.23M | $60.11M | 46.44% |
| 2012-03-31 | $51.29M | $110.87M | $59.58M | 46.26% |
| 2011-12-31 | $50.26M | $108.86M | $58.60M | 46.17% |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | $51.81M | $108.18M | $56.37M | 47.89% |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
| 2009-12-31 | $41.68M | $85.77M | $44.09M | 48.60% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |